FRCS Revision

This site is private

Enter the password to open the revision library.

Personal revision library · not clinical advice
FRCSRevision
Home / Dysplasia Syndromes / Enchondromatosis and osteochondromatosis
Dysplasia Syndromes

Enchondromatosis and osteochondromatosis

Ollier disease, Maffucci syndrome and hereditary multiple exostoses with forearm deformity.

25 questions 3 source pages 1 images 1 fact-check flags

Images appear with the first question taken from each source page — tap a question to open it.

25 questions
Q1What is Ollier's disease and how does it present?📷▸
Enchondromatosis
Enchondromatosis
  • Sporadic defect of enchondral ossification
  • Unilateral involvement --> LLD
  • Angular deformity
  • DDx: polyostotic fibrous dysplasia, OI
Q2What is Maffucci syndrome and what are its XR features?▸
  • Maffucci = Ollier's + hemangioma
  • Expanded bone, angular deformity, cutaneous haemangiomata
  • XR: Ollier changes + small rounded calcified phleboliths
Q3What are the rates of malignant transformation in enchondromatosis?▸
  • Solitary enchondroma <1%
  • Ollier's 25-30%
  • Maffucci 100%
Q4Which four planes of deformity are considered in treatment?▸
  • Coronal: valgus/varus
  • Sagittal: flexion/extension
  • Transverse: torsional
  • Longitudinal: LLD
  • Aim: well-aligned limbs in all planes
Q5What are the treatment options for deformity in enchondromatosis?▸
  • Hemiepiphysiodesis or guided growth
  • Osteotomy for acute or gradual correction
  • Combination of techniques
Q6How does enchondroma differ from osteochondroma?▸
  • Enchondroma: incomplete enchondral ossification, escape of chondroblast to metaphysis (cartilage in IM canal)
  • Enchondroma: Rubin physis hyperplasia
  • Osteochondroma: benign chondrogenic lesion from the perichondral ring
  • Osteochondroma: metaphysis hyperplasia
Q7What are the XR features of Ollier's disease?▸
  • Cartilage-containing lesion + irregular translucent area at metaphysis
  • Expanded bone
  • Polyostotic involvement
Q8Describe the XR findings of multiple hereditary exostosis at the knee.▸
  • Multiple bony protrusions of the metaphyseal region of distal femur/proximal tibia with metaphyseal tubulation
  • Pedunculated, well defined, narrow zone of transition, pointing away from the physis
  • Trabeculae within lesion continuous with the rest of the bone
  • No cortical destruction, no soft tissue calcification
Q9How do you differentiate MHE from Trevor disease?▸
  • Clinically: Trevor is younger
  • Radiologically: Trevor arise from epiphysis
  • Histologically: Trevor cartilage cap has bands of cartilage separating cancellous bone
  • Genetics: normal EXT levels in Trevor
Q10What is the risk of malignant transformation in MHE?▸
  • 5-10% lifetime risk of malignant transformation
  • Versus normal lifetime risk of any malignancy of 1 in 3
  • 1% lifetime risk per lesion, chondrosarcoma at around the 5th decade
  • Cartilage cap >2cm suspicious (normal 2-3mm)
Q11Which clinical and radiological features suggest malignant transformation?▸
  • Increase in size after puberty
  • Acute onset of pain in adults
  • Cortical destruction, soft tissue mineralization >2cm
  • MRI cartilage cap >2cm, sessile, central lesions more malignant
Q12What are the indications for surgery in MHE?▸
  • Pain from bursitis
  • Deformity (forearm bowing, genu varum and valgum)
  • Malignant transformation into chondrosarcoma
  • Excise lesion including cartilaginous cap to reduce recurrence; corrective osteotomy +/- lengthening
Q13What is the genetics and pathogenesis of MHE?▸
  • AD; EXT1 (Chr 8), EXT2 (Chr 11), EXT3 (Chr 19); EXT1 worst
  • 10% spontaneous mutation
  • Defect in the groove of Ranvier with aberrant cartilage from the perichondral ring
  • Mutations affect prehypertrophic chondrocytes; Rubin: metaphyseal hyperplasia
Q14What investigations are required in MHE?▸
  • Further XR of the scapula and pelvis (regions that cannot be palpated clinically)
  • Scannogram for lower limb alignment
  • Check the forearms clinically for bony exostosis and associated radial head dislocation
Q15What complications must be ruled out in MHE?▸
  • Local pressure symptoms (nerve, bursitis, pseudoaneurysm)
  • Deformity/growth disturbance
  • Malignancy
Q16What is the growth pattern and natural history of MHE lesions?▸
  • Sessile or pedunculated growth from the physeal plate away from the joint
  • Lesions are benign and stop growing at maturity
Q17Describe the XR findings in this skeletally immature forearm.▸
  • Shortening of the ulna with ulnar negative variance and apex radial bowing
  • Abnormal bony enlargement of the ulnar head with exostosis
  • Dislocated radial head
  • Ulnar shift of the carpus
Q18What are the surgical indications from the deformity point of view?▸
  • Ulnar shortening >1.5cm
  • Radial articular angle >30 degrees
  • Carpal translocation >60%
  • Painful subluxation of the radial head
  • Pronation <60 degrees
Q19What are the surgical indications from the MHE point of view?▸
  • Enlarging mass after puberty
  • Nerve or skin impingement, pain
  • Radiologically: cortical erosion
  • Cartilaginous cap >2cm, soft tissue mineralisation >2cm
Q20What are the options for radius reconstruction?▸
  • Proximal radius: unstable - one bone forearm; stable - radial head excision
  • Distal: osteotomy/ hemiepiphysiodesis
Q21What does the 2018 systematic review conclude about ulnar lengthening?▸
  • Restores radiologic anatomy, improves appearance and to a lesser extent objective clinical parameters short to intermediate term
  • Poor evidence that gains are maintained long term
  • Impact on QOL and function not adequately investigated
  • Considerable evidence surgery minimally impacts pre-op function
Q22What counselling points are given to the family?▸
  • Risk of malignancy
  • Risk of further deformity
  • Functional impairment may not improve with surgery - it mainly improves cosmesis
Q23What is the differential diagnosis of the forearm deformity?▸
  • Tumour
  • Malunion
  • Trevor disease (dysplasia epiphysealis hemimelia)
Q24How do you confirm the diagnosis and assess the patient?▸
  • Look for other lesions -> ?HME
  • Rule out malignancy
  • Assess other complications: ROM, nerve compression
  • Assess current function
Q25What are the details of surgical treatment?▸
  • Excise the exostosis to stop differential growth
  • Ulnar lengthening (acute vs gradual depends on length)
  • Timing of surgery is controversial

Fact check

Malignant transformation occurs in 100% of Maffucci syndrome patients — Overstated - published rates vary widely; not all patients transform — Reported rates range from about 15-40% up to 52-57%; the JBJS 1987 life-table analysis says degeneration is almost a certainty, not 100% — (medium confidence) — source